Effects of COX-2 Inhibition on Lung Cancer Cell Factors
Author Information
Author(s): Zhu Yong Ming, Azahri Nor Saadah M, Yu Danny CW, Woll Penella J
Primary Institution: University of Sheffield
Hypothesis
Inhibition of COX-2 activity might reduce expression of the pro-angiogenic factors VEGF and IL-8 in lung cancer cells.
Conclusion
COX-2 is only expressed in NSCLC cells, and while VEGF production is COX-2 dependent in these cells, IL-8 production is COX-2 independent.
Supporting Evidence
- NSCLC cell lines produced more IL-8 than VEGF.
- COX-2 was expressed only in NSCLC cell lines.
- VEGF production was reduced by COX-2 inhibition in certain NSCLC cell lines.
Takeaway
This study found that lung cancer cells make more IL-8 than another factor called VEGF, and blocking COX-2 can lower VEGF levels but not IL-8 levels.
Methodology
The study measured IL-8, VEGF, and PGE2 levels using ELISA and determined COX-1 and COX-2 expression by Western blotting.
Limitations
The study primarily used cell lines, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website